Literature DB >> 23528164

Differentiation of transitional zone prostate cancer from benign hyperplasia nodules: evaluation of discriminant criteria at multiparametric MRI.

A L Chesnais1, E Niaf, F Bratan, F Mège-Lechevallier, S Roche, M Rabilloud, M Colombel, O Rouvière.   

Abstract

AIM: To assess topographical and magnetic resonance imaging (MRI) features in characterizing prostate transitional zone (TZ) nodules.
MATERIALS AND METHODS: Two radiologists evaluated all TZ nodules visible at multiparametric MRI in 52 consecutive patients who underwent radical prostatectomy. The radiologists assessed topographical (anteroposterior and superior-inferior location, crossing of the sagittal midline) and T2-weighted (shape, presence and distinctness of capsule, distinctness of contours, presence of cysts) features, the apparent diffusion coefficient (ADC), and eight semi-quantitative and quantitative enhancement parameters derived from dynamic contrast-enhanced (DCE) imaging. The nature of the nodules was assessed using prostatectomy specimens. Five statistical methods taking into account multiple testing were used.
RESULTS: One hundred and thirty-seven nodules (117 benign, 20 malignant) were evaluated. Mean ADC, all topographical, and all T2-weighted features were significant predictors of malignancy according to at least four out of the five statistical methods. Particularly, 20/20 and 18/20 cancers involved the anterior and apical third of the TZ, respectively. None of the enhancement parameters was significantly different between cancers and benign nodules. By assessing the presence of cysts, the nodules' capsule, and their anteroposterior and superior-inferior location, 111/117 benign nodules were correctly diagnosed, without misclassifying any cancer.
CONCLUSION: Topographical, T2-weighted, and diffusion-weighted features can be used to characterize TZ nodules. DCE imaging does not seem to provide additional information.
Copyright © 2013 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23528164     DOI: 10.1016/j.crad.2013.01.018

Source DB:  PubMed          Journal:  Clin Radiol        ISSN: 0009-9260            Impact factor:   2.350


  30 in total

1.  Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard.

Authors:  L Schimmöller; M Quentin; C Arsov; R S Lanzman; A Hiester; R Rabenalt; G Antoch; P Albers; D Blondin
Journal:  Eur Radiol       Date:  2013-06-12       Impact factor: 5.315

2.  Computer-aided analysis of prostate multiparametric MR images: an unsupervised fusion-based approach.

Authors:  N Betrouni; N Makni; S Lakroum; S Mordon; A Villers; P Puech
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-01-22       Impact factor: 2.924

3.  Dynamic contrast-enhanced MR imaging of the prostate: intraindividual comparison of gadoterate meglumine and gadobutrol.

Authors:  Chau Hung Lee; Balamurugan Vellayappan; Matthias Taupitz; Bernd Hamm; Patrick Asbach
Journal:  Eur Radiol       Date:  2019-07-01       Impact factor: 5.315

4.  Diagnosis of transition zone prostate cancer using T2-weighted (T2W) MRI: comparison of subjective features and quantitative shape analysis.

Authors:  Satheesh Krishna; Nicola Schieda; Matthew Df McInnes; Trevor A Flood; Rebecca E Thornhill
Journal:  Eur Radiol       Date:  2018-08-13       Impact factor: 5.315

5.  Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.

Authors:  Yuji Iyama; Takeshi Nakaura; Kazuhiro Katahira; Ayumi Iyama; Yasunori Nagayama; Seitaro Oda; Daisuke Utsunomiya; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2017-03-13       Impact factor: 5.315

6.  PI-RADS version 2.1 scoring system is superior in detecting transition zone prostate cancer: a diagnostic study.

Authors:  Zhibing Wang; Wenlu Zhao; Junkang Shen; Zhen Jiang; Shuo Yang; Shuangxiu Tan; Yueyue Zhang
Journal:  Abdom Radiol (NY)       Date:  2020-09-09

7.  Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.

Authors:  J P Radtke; S Boxler; T H Kuru; M B Wolf; C D Alt; I V Popeneciu; S Steinemann; C Huettenbrink; C Bergstraesser-Gasch; T Klein; C Kesch; M Roethke; N Becker; W Roth; H-P Schlemmer; M Hohenfellner; B A Hadaschik
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-06-16       Impact factor: 5.554

Review 8.  Innovations in diagnostic imaging of localized prostate cancer.

Authors:  Karl Pummer; Malte Rieken; Herbert Augustin; Thomas Gutschi; Shahrokh F Shariat
Journal:  World J Urol       Date:  2014-08       Impact factor: 4.226

9.  Stiffness of benign and malignant prostate tissue measured by shear-wave elastography: a preliminary study.

Authors:  Olivier Rouvière; Christelle Melodelima; Au Hoang Dinh; Flavie Bratan; Gaele Pagnoux; Thomas Sanzalone; Sébastien Crouzet; Marc Colombel; Florence Mège-Lechevallier; Rémi Souchon
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

10.  Three-dimensional proton magnetic resonance spectroscopy and diffusion-weighted imaging in the differentiation of incidental prostate carcinoma from benign prostate hyperplasia.

Authors:  Xue-Qin Zhang; Xiang-Rong Yu; Zhong-Li Du; Xiao-Fen Miao; Jian Lu; Quan Zhou
Journal:  Oncol Lett       Date:  2018-02-27       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.